KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Deferred Taxes (2019 - 2026)

AbbVie has reported Deferred Taxes over the past 7 years, most recently at -$385.0 million for Q4 2025.

  • Quarterly Deferred Taxes rose 49.8% to -$385.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$492.0 million through Dec 2025, up 66.05% year-over-year, with the annual reading at -$492.0 million for FY2025, 66.05% up from the prior year.
  • Deferred Taxes was -$385.0 million for Q4 2025 at AbbVie, down from $193.0 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $193.0 million in Q3 2025 and troughed at -$1.4 billion in Q4 2023.
  • The 5-year median for Deferred Taxes is -$322.5 million (2023), against an average of -$383.0 million.
  • Year-over-year, Deferred Taxes crashed 1726.47% in 2022 and then surged 169.68% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$745.0 million in 2021, then soared by 30.74% to -$516.0 million in 2022, then tumbled by 169.57% to -$1.4 billion in 2023, then skyrocketed by 44.86% to -$767.0 million in 2024, then soared by 49.8% to -$385.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Deferred Taxes are -$385.0 million (Q4 2025), $193.0 million (Q3 2025), and -$272.0 million (Q2 2025).